Evidence method
Level · gp.fundamentals.capex_revenue_ratio
27.34% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CLDX · Dec 31, 2024
Celldex Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001410578-25-000216General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-2247.55% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
1.99% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
97.15% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-2778.89% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2329.77% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
487.78% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- 17.08%
- Current
- 27.34%
- Delta
- 10.26%
- Previous
- -1734.16%
- Current
- -2247.55%
- Delta
- -513.39%
- Previous
- 110.35%
- Current
- 1.99%
- Delta
- -108.36%
- Previous
- -1633.53%
- Current
- -2778.89%
- Delta
- -1145.36%
- Previous
- 1418.46%
- Current
- 2329.77%
- Delta
- 911.31%
- Previous
- 301.47%
- Current
- 487.78%
- Delta
- 186.30%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CLDX Fundamental State →Has State · Celldex Therapeutics, Inc. →Transitioned To · CLDX Fundamental State →Transitioned To · CLDX CAPEX_INTENSITY_INCREASED →Transitioned To · CLDX CASH_GENERATION_DECREASED →Transitioned To · CLDX GROWTH_DECREASED →Transitioned To · CLDX PROFITABILITY_DECREASED →Transitioned To · CLDX R_AND_D_INTENSITY_INCREASED →Transitioned To · CLDX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.